Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Healthtrust
Harvard Business School
Farmers Insurance
Express Scripts
Citi
US Army
Medtronic
US Department of Justice

Generated: December 12, 2017

DrugPatentWatch Database Preview

Galen Specialty Company Profile

« Back to Dashboard

What is the competitive landscape for GALEN SPECIALTY, and when can generic versions of GALEN SPECIALTY drugs launch?

GALEN SPECIALTY has one approved drug.

There is one US patent protecting GALEN SPECIALTY drugs.

There are five patent family members on GALEN SPECIALTY drugs in five countries.

Summary for Galen Specialty

International Patents:5
US Patents:1
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Galen SpecialtySYNERAlidocaine; tetracainePATCH;TOPICAL021623-001Jun 23, 2005RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Galen Specialty

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Galen SpecialtySYNERAlidocaine; tetracainePATCH;TOPICAL021623-001Jun 23, 2005► Subscribe► Subscribe
Galen SpecialtySYNERAlidocaine; tetracainePATCH;TOPICAL021623-001Jun 23, 2005► Subscribe► Subscribe
Galen SpecialtySYNERAlidocaine; tetracainePATCH;TOPICAL021623-001Jun 23, 2005► Subscribe► Subscribe
Galen SpecialtySYNERAlidocaine; tetracainePATCH;TOPICAL021623-001Jun 23, 2005► Subscribe► Subscribe
Galen SpecialtySYNERAlidocaine; tetracainePATCH;TOPICAL021623-001Jun 23, 2005► Subscribe► Subscribe
Galen SpecialtySYNERAlidocaine; tetracainePATCH;TOPICAL021623-001Jun 23, 2005► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Galen Specialty Drugs

Country Document Number Estimated Expiration
European Patent Office1202691► Subscribe
Japan2004510454► Subscribe
Canada2375655► Subscribe
World Intellectual Property Organization (WIPO)0103625► Subscribe
Australia6076200► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Queensland Health
Harvard Business School
McKesson
Fuji
Cerilliant
Express Scripts
UBS
Daiichi Sankyo
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot